Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and restated as follows: The information contained on the cover pages of this Schedule 13D relating to CHL, CHLP, Plantae and Mr. Weinstein is incorporated by reference. On October 20, 2026, CHLP and the Issuer entered into the October 2026 SPA, pursuant to which CHLP acquired 833,334 Common Shares at a purchase price of $1.50 per share and the October 2026 CHLP Common Warrants to purchase up to 833,334 Common Shares at an exercise price of $1.65 per share. The aggregate purchase price of $1,250,000 was satisfied in full through the application of the advance payment made by CHLP to the Issuer on June 16, 2026 pursuant to the Advance Subscription Agreement, dated June 14, 2026. CHLP acquired the October 2026 CHLP Common Shares and the October 2026 CHLP Common Warrants for investment purposes. The foregoing description of the October 2026 SPA and the October 2026 CHLP Common Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of such agreements, which are incorporated herein by reference.